Announcements Trials
Browse Landscape

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Lymphoid 1

Conditions

Cardiotoxicity 6Lymphoma, Non-Hodgkin 4Lymphoma 3Breast Neoplasms 3Prostatic Neoplasms 2Multiple Myeloma 2Leukemia 2Cardiovascular Diseases 2Small Cell Lung Carcinoma 1Obesity 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Metastatic Solid Tumors 1Metabolic Syndrome 1Melanoma 1Lymphoproliferative Disorders 1Lymphomatoid Granulomatosis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Primary Effusion 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lymphoma, AIDS-Related 1Lung Neoplasms 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Heart Failure 1Epstein-Barr Virus Infections 1

Interventions

Social Determinants of Health 2Electrocardiography 2Echocardiography 2zanubrutinib 1sofosbuvir-velpatasvir drug combination 1acalabrutinib 1Vascular Stiffness 1Standard of Care 1Restraint, Physical 1Referral and Consultation 1Quality of Life 1Pulse Wave Analysis 1Practice Guidelines as Topic 1Positron-Emission Tomography 1Physical Conditioning, Human 1Patient Navigation 1Nutrition Assessment 1Methods 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Hematologic Tests 1Health Information Exchange 1Geritol 1Fish Oils 1Fatty Acids, Omega-3 1Ethanol 1Educational Status 1Early Intervention, Educational 1Diet, Mediterranean 1Cholecalciferol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cardiovascular Diseases × Echocardiography × 1 year × Clear all
NCT05201014 2025-09-05

CASCADE

Mayo Clinic

Active not recruiting
112 enrolled

Cardiovascular Diseases, Neoplasms

NCT07041827 2025-06-27

CLARITY

The Netherlands Cancer Institute

Completed
217 enrolled
Lymphoid

Cardiovascular Diseases, Heart Failure, Lymphoma, Non-Hodgkin, Cardiomyopathies, Metabolic Syndrome, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡